New Antiviral Option for CMV Prophylaxis After Kidney Transplant
Letermovir proved noninferior to standard of care in clinical trial
Source: medpagetoday.com
📰 Danielr Kaul News
Danielr Kaul News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Danielr Kaul. Real-time updates on events, politics, business and more.
A New Antiviral Option for Cytomegalovirus Prevention After Kidney Transplant | Infectious Diseases | JAMA
Cytomegalovirus (CMV) is among the most consequential infections affecting solid organ transplant recipients. In addition to the direct consequences of viral in
United States Ann Arbor Danielr Kaul Division Of Infectious Diseases Drug Administration E Medical Center Dr
Source: jamanetwork.com
Letermovir Approved for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
The antiviral letermovir has received a new FDA indication as prophylaxis for recipients of a cytomegalovirus (CMV)-seropositive kidney transplant.
Source: renalandurologynews.com